Faculty profile

Peter Tugwell

Back to faculty

ProfessorSchool of Epidemiology and Public HealthUniversity of Ottawa

Peter Tugwell

Professor

School of Epidemiology and Public Health

Faculty of Medicine

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
142 publications in the last five years, latest in 2026.
Senior (last) author on 28 recent papers, a sign of leading a research group.
Principal investigator on 25 research grants (25 CIHR), most recently in 2023.
Supervised 2 trainees who won CIHR awards, most recently in 2013.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

400

Publications

25,738

Citations

h-index

235

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Health Equity Knowledge Synthesis Systematic Reviews Knowledge Translation Equity Vulnerable Populations Immigrant Health Primary Health Care

Latest papers

PRO EDI-A Tool to Help Systematic Reviewers Make Equity, Diversity, and Inclusion Assessments.
Cochrane evidence synthesis and methods · 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.
Seminars in arthritis and rheumatism · 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.
Annals of the rheumatic diseases · 2026

All 400 publications

Latest funding

Evidence and Gap Maps for health equity: A strategic tool to drive transformative health research priorities
CIHR · 2025 · Co-investigator
$493,424
Establishing An International Core Outcome Set for Subarachnoid Hemorrhage (SAH) - What and How to Measure Outcomes in SAH Research
CIHR · 2024 · Co-investigator
$726,752
Developing evidence-informed patient engagement guidance for economic evaluations (DEEP-ENGAGE)
CIHR · 2024 · Co-investigator
$504,925

All 51 grants and awards

From the 150 most recent of 400 publications.

PRO EDI-A Tool to Help Systematic Reviewers Make Equity, Diversity, and Inclusion Assessments.

Treweek S, Devane D, Welch V, Petkovic J, Tugwell P, Saif-Ur-Rahman KM, Pizarro AB, Ciapponi A, Gkertso I, Cerejo C, Bruhn H

Cochrane evidence synthesis and methods2026

DOI: 10.1002/cesm.70083 PMID: 42078965

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Berthelsen DB, Horgan B, Simon L, Ioannidis JPA, Goel N, Tugwell P, Balay-Dustrude E, Bartlett SJ, Bingham CO, Boers M, Bouillot C, Böhm P, Choy E, Cowern M, Dagsvik K, Djurtoft C, Furst DE, Haugegaard T, Hazlewood GS, Hoens AM, Jørgensen TS, Kelly SE, Kruzikas D, Musaus J, Richards P, Shea BJ, Strand V, Thomas M, Torralba K, Voshaar M, Weinbrecht-Mischkewitz M, Woodworth TG, Wright G, Flurey C, Christensen R, OMERACT Safety Working Group

Seminars in arthritis and rheumatism2026

DOI: 10.1016/j.semarthrit.2026.153026 PMID: 42364594

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Annfeldt TK, Händel MN, Haugegaard T, Henriksen M, Coates LC, Ogdie A, Tillett W, Goel N, Gladman DD, Orbai AM, de Wit M, Strand V, Mease PJ, FitzGerald O, Helliwell PS, Tugwell P, Leung YY, Christensen R

Annals of the rheumatic diseases2026

DOI: 10.1016/j.ard.2026.05.013 PMID: 42248769

Risk of Bias in Experiments, Quasi-Experiments and Natural Experiments Across Disciplines: Discussion Paper and Assessment Framework.

Sharma Waddington H, Wilson DB, Pigott T, Aloe AM, Tugwell P, Welch V, Stewart G

Campbell systematic reviews2026

DOI: 10.1177/18911803261435894 PMID: 42282093

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Berthelsen DB, Haugegaard T, Kamso MM, Tugwell P, Simon LS, Ioannidis JPA, Flurey C, Boers M, Voshaar M, Richards P, Shea B, Furst DE, Singh JA, Stevens R, Woodworth T, Bartlett SJ, Hazlewood GS, Christensen R, OMERACT Safety Working Group

Seminars in arthritis and rheumatism2026

DOI: 10.1016/j.semarthrit.2026.152983 PMID: 42034888

Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: a key concept in clinical epidemiology.

Christensen R, Berthelsen DB, Tugwell P, Golder S, Qureshi R, Mayo-Wilson E, Simon LS, Kwong J, Williamson PR, Vohra S

Journal of clinical epidemiology2026

DOI: 10.1016/j.jclinepi.2026.112218 PMID: 41802580

Evaluation of the replicability of systematic reviews with meta-analyses of the effects of health interventions.

Hamilton DG, McKenzie JE, Nguyen PY, Rethlefsen ML, McDonald S, Brennan SE, Fidler FM, Higgins JPT, Kanukula R, Karunananthan S, Maxwell LJ, Moher D, Nakagawa S, Nunan D, Tugwell P, Welch VA, Page MJ

Research synthesis methods2026

DOI: 10.1017/rsm.2025.10064 PMID: 41992899

[Not Available].

Dewidar O, Shamseer L, Melendez-Torres GJ, Akl EA, Ramke J, Wang X, Oloyede O, Young T, Nicholls SG, Marshall Z, Kennedy M, Hardy BJ, Rizvi A, Ghogomu E, Rader T, Waddington HS, Shea B, Nguilefem MN, Ellingwood H, Wolfenden L, Tufte J, Horsley T, Pottie K, Cuervo LG, Juando-Prats C, Feng C, Sharp MK, Little J, Owusu-Addo E, Francis D, Kredo T, Mahande MJ, Chamberlain C, Pantoja T, von Elm E, Bhutta ZA, Tugwell P, Wiysonge CS, Funnell S, Jull J, Mbuagbaw L, Welch V

Revista panamericana de salud publica = Pan American journal of public health2026

DOI: 10.26633/rpsp.2026.37 PMID: 41947917

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report.

Gazel U, Barnes E, Jones B, Terrett A, Voshaar M, Hoogland W, March L, Beaton D, Khoo T, Chin A, Shea B, Tugwell P, Proudman S, Flurey CA

Seminars in arthritis and rheumatism2026

DOI: 10.1016/j.semarthrit.2026.152948 PMID: 41730817

"Identifying Social Factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research": explanation and elaboration to support the standardized reporting of equity-relevant data.

Karran EL, Cashin AG, Chiarotto A, Sharma S, Barker T, Boyd MA, Maxwell LJ, Mohabir V, Petkovic J, Tugwell P, Moseley GL

Journal of clinical epidemiology2026

DOI: 10.1016/j.jclinepi.2026.112136 PMID: 41534591

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Peter Tugwell

Research

Latest papers

Latest funding

PRO EDI-A Tool to Help Systematic Reviewers Make Equity, Diversity, and Inclusion Assessments.

Development of a single&#x2011;item patient&#x2011;reported measure of treatment side&#x2011;effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Risk of Bias in Experiments, Quasi-Experiments and Natural Experiments Across Disciplines: Discussion Paper and Assessment Framework.

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: a key concept in clinical epidemiology.

Evaluation of the replicability of systematic reviews with meta-analyses of the effects of health interventions.

[Not Available].

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report.

"Identifying Social Factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research": explanation and elaboration to support the standardized reporting of equity-relevant data.

Frequent collaborators

Vivian Welch

Beverley Shea

Kevin Pottie

Dorcas Beaton

Lawrence Mbuagbaw

Elie Akl

Holger Schunemann

Peter Tugwell

Elizabeth Kristjansson

Karine Toupin April

George Wells

David Moher

Janet Jull

Janet Jull

Janet Jull

Tanya Horsley

Julian Little

Billie-Jo Hardy

Kevin Pottie

Sarah Funnell

Sarah Funnell

Sathya Karunananthan

Cheryl Barnabe

Thomas Piggott

Andrea Darzi

Robby Nieuwlaat

Braden Manns

Kednapa Thavorn

Lucie Brosseau

Kednapa Thavorn

Reem Adel Mustafa

Romina Brignardello

Alfonso Iorio

Gordon Guyatt

Nancy Santesso

Arnav Agarwal

Derek Chu

Lehana Thabane

Jeremy Grimshaw

Sunita Vohra

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.